Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,942
Total Claims
$1.1M
Drug Cost
583
Beneficiaries
$1,803
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,825 Geriatric Medicine providers
-67%
Opioid rate vs peers
0.8% vs 2.6% avg
+46%
Cost per patient vs peers
$1,803 vs $1,237 avg
+81%
Brand preference vs peers
16.6% vs 9.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.8%
Opioid Rate
101
Opioid Claims
$1,628
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,969 claims · $802K
Generic: 9,889 claims · $245K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 573 | $239K |
| Darbepoetin Alfa In Polysorbat | 26 | $63K |
| Rivaroxaban | 123 | $55K |
| Lipase/Protease/Amylase | 23 | $45K |
| Semaglutide | 23 | $34K |
| Sitagliptin Phosphate | 37 | $33K |
| Mirabegron | 42 | $28K |
| Fluticasone/Vilanterol | 53 | $26K |
| Epoetin Alfa | 21 | $23K |
| Bumetanide | 333 | $20K |
| Potassium Chloride | 251 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 44 | $14K |
| Empagliflozin | 22 | $13K |
| Budesonide/Formoterol Fumarate | 24 | $13K |
| Insulin Glargine,hum.Rec.Anlog | 34 | $13K |
Prescribing Profile
Patient Profile
81
Avg Age
70%
Female
1.81
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About